| 1 |
Park HW, Yoon CH, Kang SH, et al. Early- and late-term clinical outcome and their predictors in patients with ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction. Int J Cardiol 2013;169:254-61.
DOI
|
| 2 |
Norhammar A, Malmberg K, Diderholm E, et al. Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization. J Am Coll Cardiol 2004;43:585-91.
DOI
|
| 3 |
Park HW, Kang MG, Kim K, et al. Long-term prognosis and clinical characteristics of patients with newly diagnosed diabetes mellitus detected after the first acute myocardial infarction: from the KAMIR-NIH registry. Korean Circ J. 2018;48:134-47.
DOI
|
| 4 |
Aguilar D, Solomon SD, Kober L, et al. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. Circulation 2004;110:1572-8.
DOI
|
| 5 |
Ertelt K, Brener SJ, Mehran R, Ben-Yehuda O, McAndrew T, Stone GW. Comparison of outcomes and prognosis of patients with versus without newly diagnosed diabetes mellitus after primary percutaneous coronary intervention for ST-elevation myocardial infarction (the HORIZONS-AMI Study). Am J Cardiol 2017;119:1917-23.
DOI
|
| 6 |
Standards of medical care in diabetes-2016: summary of revisions. Diabetes Care 2016;39 Suppl 1:S4-5.
DOI
|
| 7 |
Chamberlain JJ, Rhinehart AS, Shaefer CF Jr, Neuman A. Diagnosis and management of diabetes: synopsis of the 2016 American Diabetes Association standards of medical care in diabetes. Ann Intern Med 2016;164:542-52.
DOI
|
| 8 |
Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 2011;58:e44-122.
DOI
|
| 9 |
Stefanini GG, Holmes DR Jr. Drug-eluting coronary-artery stents. N Engl J Med 2013;368:254-65.
DOI
|
| 10 |
Bangalore S, Kumar S, Fusaro M, et al. Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials. BMJ 2012;345:e5170.
DOI
|
webmaster
